Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study
2011

Risk of Blood Clots in Hospitalized Patients with Immune Diseases

publication Evidence: moderate

Author Information

Author(s): Ramagopalan Sreeram V, Wotton Clare J, Handel Adam E, Yeates David, Goldacre Michael J

Primary Institution: Wellcome Trust Centre for Human Genetics, University of Oxford

Hypothesis

Do people admitted to hospital with immune-mediated diseases have an increased risk of venous thromboembolism (VTE)?

Conclusion

People admitted to hospital with immune-mediated diseases may be at an increased risk of subsequent VTE.

Supporting Evidence

  • Elevated risks of VTE were found in patients with autoimmune diseases.
  • Rate ratios for systemic lupus erythematosus were significantly high across different populations.
  • The study used a large dataset to analyze the risk of VTE in immune-mediated diseases.

Takeaway

If you go to the hospital with certain immune diseases, you might be more likely to get blood clots afterwards.

Methodology

The study analyzed linked hospital admission and death certificate records to determine VTE rates in patients with immune-mediated diseases.

Potential Biases

Potential bias due to unmeasured migration and lack of data on treatment and confounding factors.

Limitations

The study is exploratory and based on prevalent cases, lacking clinical and laboratory data.

Participant Demographics

The study included a diverse population from the Oxford NHS region and the whole of England.

Statistical Information

P-Value

<0.001

Confidence Interval

3.61 (2.36 to 5.31) for systemic lupus erythematosus

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1741-7015-9-1

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication